Brief: GB Sciences Sells Its Louisiana Medical Marijuana Business
17/09/2019 17:36
Sept 17 (Reuters) - GB Sciences Inc GBLX.PK :
* PRESS RELEASE - GB SCIENCES SELLS ITS LOUISIANA MEDICAL
MARIJUANA BUSINESS AT A $32 MILLION TOTAL VALUATION
* GB SCIENCES INC - SALE OF ITS 50% OWNERSHIP STAKE IN GB
SCIENCES
LOUISIANA TO WELLCANA PLUS
Source text for Eikon: ID:nCNWRNSzTa
Further company coverage: GBLX.PK
((Reuters.briefs@thomsonreuters.com;))
Recent news on GB Sciences
See all newsBrief: Gb Sciences' Plant-Based Formulations Designed To Treat Anxiety Achieve Statistical Significance In Animal Study
Brief: Gb Sciences Inc - Reported Positive Results From A Study Of Its Potential Treatment For Cytokine Release Syndrome
Brief: GB Sciences Sells Its Louisiana Medical Marijuana Business
Brief: GB Sciences Files Novel Patent Application
Brief: GB Sciences Announces The Appointment Of John Davis As Executive VP And General Counsel